cefixime has been researched along with Fever in 11 studies
Cefixime: A third-generation cephalosporin antibiotic that is stable to hydrolysis by beta-lactamases.
cefixime : A third-generation cephalosporin antibiotic bearing vinyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It is used in the treatment of gonorrhoea, tonsilitis, pharyngitis, bronchitis, and urinary tract infections.
Fever: An abnormal elevation of body temperature, usually as a result of a pathologic process.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objective of this study was to test the efficacy of oral ciprofloxacin in the treatment of lower risk febrile neutropenia (LRFN) in children treated for malignant diseases." | 9.09 | Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia. ( Armada, A; Cáceres, E; Casimir, L; Debbag, R; Fernández, C; Firpo, V; Latella, A; Paganini, H; Rodriguez-Brieshcke, T; Zubizarreta, P, 2001) |
| "The objective of this study was to test the efficacy of oral ciprofloxacin in the treatment of lower risk febrile neutropenia (LRFN) in children treated for malignant diseases." | 5.09 | Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia. ( Armada, A; Cáceres, E; Casimir, L; Debbag, R; Fernández, C; Firpo, V; Latella, A; Paganini, H; Rodriguez-Brieshcke, T; Zubizarreta, P, 2001) |
| " One child developed bacteremia 3 days after completing the course of cefixime, and one had splenic sequestration on the fourth study day." | 5.08 | Outpatient therapy with ceftriaxone and oral cefixime for selected febrile children with sickle cell disease. ( Dancy, RM; Day, SW; Harris, SC; Wang, WC; Wilimas, JA; Williams, LL, 1996) |
| "Febrile neutropenia is a heterogeneous condition." | 2.69 | Oral administration of cefixime to lower risk febrile neutropenic children with cancer. ( Armada, AA; Casimir, L; De Martino, MG; Debbag, R; Fernandez, C; Paganini, HR; Rodriguez-Brieshcke, MT; Sarkis, CM; Zubizarreta, PA, 2000) |
| "We sought to describe the risk of recurrence at 1 month after the end of treatment for FUTI due to ESBL-E according to the oral relay therapy used." | 1.62 | Relay oral therapy in febrile urinary tract infections caused by extended spectrum beta-lactamase-producing Enterobacteriaceae in children: A French multicenter study. ( Andriantahina, I; Angoulvant, F; Birgy, A; Bonacorsi, S; Cixous, E; Cohen, R; Craiu, I; De Pontual, L; Dommergues, MA; Dubos, F; Gajdos, V; Georget, E; Gillet, Y; Grimprel, E; Jung, C; Launay, E; Levy, C; Lignieres, G; Madhi, F; Pinquier, D; Rybak, A; Soussan-Banini, V; Vignaud, O, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Lignieres, G | 1 |
| Birgy, A | 1 |
| Jung, C | 1 |
| Bonacorsi, S | 1 |
| Levy, C | 1 |
| Angoulvant, F | 1 |
| Grimprel, E | 1 |
| Dommergues, MA | 1 |
| Gillet, Y | 1 |
| Craiu, I | 1 |
| Rybak, A | 1 |
| De Pontual, L | 1 |
| Dubos, F | 1 |
| Cixous, E | 1 |
| Gajdos, V | 1 |
| Pinquier, D | 1 |
| Andriantahina, I | 1 |
| Soussan-Banini, V | 1 |
| Georget, E | 1 |
| Launay, E | 1 |
| Vignaud, O | 1 |
| Cohen, R | 2 |
| Madhi, F | 2 |
| Pokharel, S | 1 |
| Karki, M | 1 |
| Acharya, B | 1 |
| Marasini, B | 1 |
| Arjyal, A | 1 |
| Sultan, BA | 1 |
| Fasih, N | 1 |
| Qaiser, S | 1 |
| Khan, E | 1 |
| Zafar, A | 1 |
| Irfan, S | 1 |
| Finnell, SM | 1 |
| Carroll, AE | 1 |
| Downs, SM | 1 |
| Biscardi, S | 1 |
| Bingen, E | 1 |
| Jaby, O | 1 |
| Epaud, R | 1 |
| Girmenia, C | 1 |
| Russo, E | 1 |
| Carmosino, I | 1 |
| Breccia, M | 1 |
| Dragoni, F | 1 |
| Latagliata, R | 1 |
| Mecarocci, S | 1 |
| Morano, SG | 1 |
| Stefanizzi, C | 1 |
| Alimena, G | 1 |
| Williams, LL | 1 |
| Wilimas, JA | 1 |
| Harris, SC | 1 |
| Day, SW | 1 |
| Dancy, RM | 1 |
| Wang, WC | 1 |
| Paganini, HR | 1 |
| Sarkis, CM | 1 |
| De Martino, MG | 1 |
| Zubizarreta, PA | 1 |
| Casimir, L | 2 |
| Fernandez, C | 2 |
| Armada, AA | 1 |
| Rodriguez-Brieshcke, MT | 1 |
| Debbag, R | 2 |
| Reed, K | 1 |
| Newton, W | 1 |
| Shenep, JL | 1 |
| Flynn, PM | 1 |
| Baker, DK | 1 |
| Hetherington, SV | 1 |
| Hudson, MM | 1 |
| Hughes, WT | 1 |
| Patrick, CC | 1 |
| Roberson, PK | 1 |
| Sandlund, JT | 1 |
| Santana, VM | 1 |
| Sixbey, JW | 1 |
| Slobod, KS | 1 |
| Paganini, H | 1 |
| Rodriguez-Brieshcke, T | 1 |
| Zubizarreta, P | 1 |
| Latella, A | 1 |
| Firpo, V | 1 |
| Armada, A | 1 |
| Cáceres, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effect of Bladder Stimulation Technique on Urine Specimen Collection in Newborns: A Randomized Controlled Study[NCT05416736] | 64 participants (Actual) | Interventional | 2021-10-15 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for cefixime and Fever
| Article | Year |
|---|---|
Technical report—Diagnosis and management of an initial UTI in febrile infants and young children.
Topics: Antibiotic Prophylaxis; Cefixime; Fever; Humans; Infant; Prevalence; Pyelonephritis; Radiography; Re | 2011 |
4 trials available for cefixime and Fever
| Article | Year |
|---|---|
Outpatient therapy with ceftriaxone and oral cefixime for selected febrile children with sickle cell disease.
Topics: Administration, Oral; Adolescent; Anemia, Sickle Cell; Anti-Infective Agents; Bacteremia; Bacterial | 1996 |
Oral administration of cefixime to lower risk febrile neutropenic children with cancer.
Topics: Administration, Oral; Adolescent; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Cefixime; | 2000 |
Oral cefixime is similar to continued intravenous antibiotics in the empirical treatment of febrile neutropenic children with cancer.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Cefixime; Cephalosporins; Child; Chi | 2001 |
Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia.
Topics: Administration, Oral; Adolescent; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antineopla | 2001 |
6 other studies available for cefixime and Fever
| Article | Year |
|---|---|
Relay oral therapy in febrile urinary tract infections caused by extended spectrum beta-lactamase-producing Enterobacteriaceae in children: A French multicenter study.
Topics: Administration, Oral; Adolescent; Amoxicillin-Potassium Clavulanate Combination; beta-Lactamases; Ce | 2021 |
Outbreak of acute undifferentiated febrile illness in Kathmandu, Nepal: clinical and epidemiological investigation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Cefixime; Child; Di | 2020 |
Mixed Salmonella infection: a report of two cases from the Aga Khan University Hospital, Karachi.
Topics: Anti-Bacterial Agents; Bacteremia; Cefixime; Ceftriaxone; Child, Preschool; Female; Fever; Humans; M | 2013 |
Combined relay therapy with oral cefixime and clavulanate for febrile urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli.
Topics: Administration, Oral; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cefixime; Chil | 2013 |
Early hospital discharge with oral antimicrobial therapy in patients with hematologic malignancies and low-risk febrile neutropenia.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Infective Agents; Bacterial Infections; Cefixime | 2007 |
Oral or IV antibiotics for the treatment of febrile children with UTIs?
Topics: Administration, Oral; Anti-Infective Agents, Urinary; Cefixime; Cefotaxime; Cephalosporins; Child, P | 1999 |